Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 June;55(3)

CURRENT ISSUETHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Journal on Nuclear Medicine and Molecular Imaging


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


Frequency: Quarterly

ISSN 1824-4785

Online ISSN 1827-1936


eTOC

 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 June;55(3)

 FOREWORD CLINICAL OUTCOMES OF AMYLOID IMAGIN IN CROSS SECTIONAL AND LONGITUDINAL STUDIES 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 June;55(3):223-4

Brain amyloid imaging: the challenge of the third millennium

Pupi A., Mosconi L.


 REVIEWS CLINICAL OUTCOMES OF AMYLOID IMAGIN IN CROSS SECTIONAL AND LONGITUDINAL STUDIES 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 June;55(3):225-36

Alzheimer’s disease: genetic basis and amyloid imaging as endophenotype

Berti V., Nacmias B., Bagnoli S., Sorbi S.


 REVIEWS CLINICAL OUTCOMES OF AMYLOID IMAGIN IN CROSS SECTIONAL AND LONGITUDINAL STUDIES 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 June;55(3):237-49

The dynamic marker hypothesis of Alzheimer’s disease and its implications for clinical imaging

Cavedo E., Frisoni G. B.


 REVIEWS CLINICAL OUTCOMES OF AMYLOID IMAGIN IN CROSS SECTIONAL AND LONGITUDINAL STUDIES 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 June;55(3):250-64

FDG- and amyloid-PET in Alzheimer’s disease: is the whole greater than the sum of the parts?

Mosconi L., McHugh P. F.


 REVIEWS CLINICAL OUTCOMES OF AMYLOID IMAGIN IN CROSS SECTIONAL AND LONGITUDINAL STUDIES 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 June;55(3):265-79

Amyloid imaging as a surrogate marker in clinical trials in Alzheimer’s disease

Scheinin Noora M., Scheinin M., Rinne J. O.


 SPECIAL ARTICLE CLINICAL OUTCOMES OF AMYLOID IMAGIN IN CROSS SECTIONAL AND LONGITUDINAL STUDIES 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 June;55(3):280-300

Current research in nuclear medicine and molecular imaging in Italy: highlights of the 10th National Congress of the Italian Association of Nuclear Medicine and Molecular Imaging

Cuocolo A.


 ORIGINAL ARTICLES CLINICAL OUTCOMES OF AMYLOID IMAGIN IN CROSS SECTIONAL AND LONGITUDINAL STUDIES 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 June;55(3):301-9

Improved visual [123I]FP-CIT SPECT interpretation for evaluation of parkinsonism by visual rating of parametric distribution volume ratio images

Meyer P. T., Winz O. H., Dafotakis M., Werner C. J., Krohn T., Schäfer W. M.


 ORIGINAL ARTICLES CLINICAL OUTCOMES OF AMYLOID IMAGIN IN CROSS SECTIONAL AND LONGITUDINAL STUDIES 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 June;55(3):310-23

Novel series of 177Lu-labeled bombesin derivatives with amino acidic spacers for selective targeting of human PC-3 prostate tumor cells

Pujatti P. B., Santos J. S., Couto R. M., Melero L. T. U. H., Suzuki M. F., Soares C. R. J., Grallert S. R. M., Mengatti J., De Araújo E. B.


 ORIGINAL ARTICLES CLINICAL OUTCOMES OF AMYLOID IMAGIN IN CROSS SECTIONAL AND LONGITUDINAL STUDIES 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 June;55(3):324-33

Influence of PET/CT on radiologists and contrast-enhanced CT on nuclear medicine physicians in patients with lymphoma

Ouvrier M. J., Diologent B., Edet-Sanson A., Callonnec F., Hitzel A., Pesquet A. S., Hapdey S., Modzelewski R., Thillays M., Menard J. F., Jardin F., Tilly H., Vera P.


top of page